Capecitabine and mitomycin C as third-line therapy for patients with metastatic colorectal cancer resistant to fluorouracil and irinotecan

Protracted venous infusion 5-fluorouracil (5FU) combined with mitomycin C (MMC) has demonstrated significant activity against metastatic colorectal cancer. Owing to potential synergy based upon upregulation of thymidine phosphorylase by MMC, the combination of capecitabine and MMC may improve outcom...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Chong, G, Dickson, J L B, Cunningham, D, Norman, A R, Rao, S, Hill, M E, Price, T J, Oates, J, Tebbutt, N
Формат: Artigo
Язык:Inglês
Опубликовано: Nature Publishing Group 2005
Предметы:
Clinical Study
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC2361607/
https://ncbi.nlm.nih.gov/pubmed/16091760
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6602733
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы